Table 3. Polymorphisms in plasma treated P. aeruginosa variants.

Gene Product	Variant	Change	Position	Polymorphism type
Probable pyridoxamine 5-phosphate oxidase followed by phenazine biosynthesis protein	5P2	C -> T	6,349,784	SNP (transition)
Phenazine biosynthesis protein PhzE	2P1, 2P2	A -> G	6,351,727	SNP (transition)
Phenazine biosynthesis protein PhzD	2P2, 5P1, 5P2	T -> C	6,353,019	SNP (transition)
	2P1, 2P2, 5P1, 5P2	T -> C	6,353,125	SNP (transition)
Putative transcriptional regulator (AAA domain protein)	2P1, 2P2	C -> T	1,197,847	SNP (transition)
Diaminopimelate decarboxylase	2P2	T -> A	2,157,427	SNP (transversion)
Conjugal transfer protein	2P1	G -> C	2,945,334	SNP (transversion)
	2P1, 2P2	G -> A	2,945,346	SNP (transition)
	2P1, 2P2	GT -> AC	2,945,350	Substitution
Intergenic region between 16S RNA gene and putative membrane protein	5P1	T -> G	5,174,776	SNP (transversion)

(2P1, 2P2 = recovered after 2 min plasma treatment; 5P1, 5P2 = recovered after 5 min plasma treatment)